Modulation of multidrug resistance-associated protein 1 (MRP1) by p53 mutant in Saos-2 cells.
The p53 tumor suppressor gene is one of the most frequently mutated genes in human cancer and the mutation is correlated with a poor prognosis in cancer therapy. Upregulation of multidrug resistance-associated protein 1 (MRP1) and increase in drug resistance have been found to be induced by p53 mutation. Human osteosarcoma Saos-2 cells, a p53-null cell line, was transfected with p53 with mutations at codon 143 (V to A), 175 (R to H), 248 (R to W), 273 (R to H) and 281 (D to G). Among the different transfectants, overexpression (about 42-fold) of MRP1 was detected in p53-R175H cells. Furthermore, the p53-R175H cells were 2.5-fold more resistant to doxorubicin (DOX) and had a 4-fold greater DOX efflux rate than the control cells 1 h after DOX treatment. Transfection with antisense MRP1 oligonucleotides demonstrated a DOX sensitization effect (about 2-fold) in p53-R175H transfectants but not in control cells. In addition, transfection with antisense p53 oligonucleotides greatly suppressed MRP1 expression and reversed DOX resistance in p53-R175H cells but had no effect in control cells. The results suggested that p53-R175H might induce MRP1 expression and DOX resistance in cells.
Tsang
Wing-Pui
WP
Department of Biochemistry, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, Peoples Republic of China.
Chau
Sophia P Y
SP
Fung
Kwok-Pui
KP
Kong
Siu-Kai
SK
Kwok
Tim-Tak
TT
D004317:Doxorubicin; D016158:Genes, p53; D006801:Humans; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000378:metabolism*; D009154:Mutation; D012516:Osteosarcoma / Q000235:genetics*; D014162:Transfection; D014407:Tumor Cells, Cultured
D004317:Doxorubicin; D027425:ATP-Binding Cassette, Sub-Family C Proteins; C421109:multidrug resistance-associated protein 1